Adam Nicolson, 57, has entered remission after becoming the first person in Scotland to receive CAR-T cell therapy for myeloma at Glasgow's Queen Elizabeth University Hospital. The treatment involves modifying a patient's own immune cells to target disease, a method researchers are now exploring for use in treating autoimmune conditions.